On February 4, 2023, David R. Epstein, a member of the Board of Directors of Evelo Biosciences, Inc., notified the Company of his intention to resign from the Company's Board, effective immediately. Mr. Epstein advised the Company that his resignation was not due to any disagreement with the Company on any matter relating to its operations, policies or practices. Following Mr. Epstein's resignation, the size of the Company's Board was reduced from ten to nine directors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -99.67% | 0.00% | -99.67% |
05-02 | North American Morning Briefing : Stock Futures -2- | DJ |
04-25 | North American Morning Briefing : More Tech -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-99.67% | 1.14M | |
+16.54% | 122B | |
+20.11% | 115B | |
+21.22% | 26.64B | |
-23.50% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-18.65% | 15.49B | |
+61.93% | 14.83B | |
+2.69% | 13.67B |
- Stock Market
- Equities
- EVLO Stock
- News Evelo Biosciences, Inc.
- David R. Epstein Intends to Resign from Evelo Biosciences, Inc.'s Board